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Abstract
Objective: To evaluate the effects of conventional treatment of chronic functional constipation on total and 
segmental colonic transit times and on orocecal transit time.
Methods: A total of 34 consecutive patients with functional constipation attending a specialized outpatient clinic 
were included in the study. Total and segmental colonic transit times were assessed using radiopaque markers. Hydrogen 
breath test was used to evaluate lactulose and bean orocecal transit times. Treatment consisted of disimpaction, 
general and dietary fiber intake instruction, and mineral oil administration.
Results: At admission, colonic dysmotility was found in 71.9% (23/32) of patients. All patients who complied 
with the treatment showed improvement of clinical symptoms after 6 weeks of treatment, when 82.6% (19/23) of 
those with dysmotility at admission returned to normal or reduced the severity of colonic transit patterns. Transit 
time decreased (medians) between admission and eighth week of treatment: lactulose orocecal transit (from 70 to 50 
minutes, p = 0.002), bean orocecal transit (from 240 to 220 minutes, p = 0.002), and total colonic transit (from 69.5 
to 37.0 hours, p = 0.001). The need for mineral oil therapy for constipation after a 12-month treatment was associated 
with persistence of total colonic transit higher than 62 hours at the eighth week of treatment (p = 0.014).
Conclusion: The conventional therapeutic approach yielded good results regardless of the presence or not of 
colonic dysmotility at inclusion in the study. Digestive tract motility abnormalities in functionally constipated children 
may be reversed, and may be secondary to constipation.
J Pediatr (Rio J). 2009;85(4):322-328: Gastrointestinal transit, constipation, therapy, pediatrics.
Introduction
The conventional treatment of chronic functional 
constipation involves, basically, the following procedures: 
fecal disimpaction and maintenance to prevent reimpaction 
using a high-fiber diet, instruction in the physiology of 
evacuation, and laxative therapy.1,2
In the etiology of chronic constipation, just as all 
functional diseases of the digestive tract, there is an 
interaction of biopsychosocial factors,3 with an emphasis 
on the vicious circle of pain during defecation, leading 
to fecal retention, harder stools, and even more painful 
defecation.1,3 It also involves constitutional factors, a 
low-fiber diet, and motility disorders of the digestive tract 
characterized by an increase in intestinal transit time, 
especially in the colon.1,4,5
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An increase in total colonic transit time is observed in 
about half of the patients with chronic constipation.1,4-6 
Among various patterns of colonic dysmotility, outlet 
obstruction4,5 is traditionally considered the most frequent 
pattern; however, in our experience, an expressive 
number of patients shows delayed transit time in the right 
colon,6,7 featuring colonic stasis. Little is known about the 
pathophysiological mechanisms involved in the genesis of 
colonic motility disorders.1,8 Painful defecation episodes, 
as a trigger for constipation, are likely to lead to stool 
withholding maneuvers which result in lumpy and hard 
stools. This process, over time, may cause rectal and 
sigmoid distension due to fecal continence.8
Hypothetically, distension of the colonic wall may 
compromise its contraction and propulsive force, or 
even be accompanied by the absence of high-amplitude 
peristaltic colonic waves, which propel stool toward the 
rectum. This situation has been described in children with 
severe refractory constipation, in whom colonic manometry 
did not reveal high-amplitude peristaltic colonic waves, 
even after stimulation of a meal (gastrocolic reflex) or 
administration of a peristaltic stimulant.9 Theoretically, 
fecaloma emptying and maintenance treatment could 
also be accompanied by a reduction in colon size with 
recovery of contraction force. These processes could 
affect colonic transit time. Classic studies with healthy 
adult women showed that inflation of rectal balloon 
or voluntary suppression of defecation lead to delayed 
gastric emptying, which is called cologastric brake.10,11 
In children, using the hydrogen breath test after a bean 
test meal, we demonstrated delayed orocecal transit time 
in chronic functional constipation with increased total 
colonic transit time.6 Thus, rectal fecal impaction may 
cause disorders secondary to colonic motility, gastric 
emptying, and small bowel transit. Only a few articles 
have analyzed the evolution of the colonic transit time 
during conventional treatment of chronic constipation, 
some of them focusing on the effect of dietary fibers or 
prokinetic drugs on transit time.12-16
Therefore, the objective of the present study is to 
analyze the effects of conventional treatment of chronic 
functional constipation in patients attending a referral 
outpatient clinic on clinical symptoms, total and segmental 
colonic transit times, and lactulose and bean test meal 
orocecal transit times.
Patients and methods
Patients
The sample was composed of 34 patients with clinical 
diagnosis of chronic functional constipation, consecutively 
admitted to the Constipation Clinic of the Discipline of 
Pediatric Gastroenterology, Universidade Federal de São 
Paulo – Escola Paulista de Medicina (UNIFESP-EPM), São 
Paulo, southeastern Brazil. Patients unable to perform 
voluntary collection of air samples for the hydrogen breath 
test, using antibiotics in the 4 weeks prior to examination, 
with constipation secondary to Hirschsprung’s disease, 
spinal or anal anomalies, metabolic diseases, and cerebral 
palsy were excluded from the study.
Chronic constipation was characterized by hard stools 
that were painful or difficult to pass, associated or not 
with longer intervals between evacuations, blood mixed 
with stools, fecal retention, and soiling for over a 3-month 
period.1,6,7,13 When necessary, anorectal manometry was 
performed, as well as additional examinations, to rule out 
other non-functional causes of chronic constipation as 
recommended.1,2,17
Study design
In this prospective cases series of patients with chronic 
functional constipation, we assessed lactulose and bean test 
meal orocecal intestinal transit times (5-day interval between 
each test), oroanal transit time of carmine dye, and total and 
segmental colonic transit times with radiopaque markers. 
These measurements were conducted at admission (before 
treatment started) and at the sixth week of treatment.
At month 12, after mineral oil was discontinued for at 
least 15 days, we reassessed bean test meal orocecal transit 
time and oroanal transit time of carmine dye.
Methods
Clinical information and data collection
An individual standardized form including the following 
clinical parameters was used: defecation frequency, pain 
during defecation, fear or effort during defecation, fecal 
retention, stool consistency and shape, presence of soiling, 
blood mixed with stools, and abdominal distension and 
pain. A complete physical examination, including a rectal 
examination, was also performed.
Follow-up appointments were conducted every 2 
weeks to collect relevant clinical information. In addition, 
a physical examination focusing on fecal impaction was 
performed. All assessments were carried out by the same 
investigator (A.C.F.S.).
Therapy regimen
At inclusion in the study, when necessary, disimpaction 
was performed with phosphate enema for 2 to 5 days. 
Patients were then prescribed a high-fiber diet and mineral 
oil at a dose of 1-3 mL/kg/day, in two divided doses. General 
instruction in the physiology of evacuation and bowel training 
including defecation in the toilet after meals were also part 
of the therapy regimen. At follow-up appointments, when 
necessary, mineral oil dose was adjusted. In the case of 
reimpaction, disimpaction procedures were repeated.1,18
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Hydrogen breath test to assess orocecal transit time
The hydrogen breath test was used to assess orocecal 
transit time after ingestion of lactulose and a test meal of 
cooked beans.
Tests were performed after a 12-hour fast. Before 
examinations, oral cleaning was performed with 0.05% 
chlorhexidine. Stools were collected and breath hydrogen 
concentration was determined, respectively, using the 
GaSample system and a model 12i Quintron Microlyser gas 
chromatograph, both purchased from Quintron Instrument 
Co. Inc. (Menomonee Falls, Wisconsin, USA).6,7
Orocecal transit time was defined as the time between 
the ingestion of lactulose or beans and a rise of 10 ppm 
in baseline breath hydrogen concentration, in each of two 
consecutive samples.5
To assess lactulose orocecal transit time, after collecting 
baseline fasting samples of end-expired air, a 10-g 10% 
dilute lactulose solution was administered orally. After the 
ingestion of lactulose, serial 10-minute samples of end-
expired air were collected for 180 minutes (end of the test). 
Cases in which a minimum 10-ppm rise was not achieved 
in the fasting breath hydrogen concentration, the test was 
extended to 240 minutes.6
The child was defined as not producing hydrogen when 
peak hydrogen in exhaled air was lower than 10 ppm in 
relation to baseline in samples collected until 240 minutes 
in the lactulose breath test.5
Total and segmental colonic transit times
Total and segmental colonic transit times were assessed 
using radiopaque markers, according to the technique 
described by Metcalf et al.19 For this examination, three 
capsules with 24 radiopaque markers of three distinctive 
types were used, as described previously in sufficient 
detail.6,7 Each child ingested one capsule with 24 markers 
on three consecutive mornings. On the fourth day, a plain 
anteroposterior abdominal radiograph was performed. An 
additional radiograph was performed at day 7 if more 
than 80% of the markers remained in the previous film. 
Radiographs were performed using high-sensitivity and 
high-kilovoltage films, allowing a reduction in radiation 
dose of approximately 1/4 in relation to conventional 
radiographs.
Total and segmental colonic transit times were calculated 
according to a previously described formula.19 The patterns 
of colonic motility disorder were defined according to the 
following criteria20-22:
- Outlet obstruction: delayed rectosigmoid transit time;
- Distal obstruction: delayed left colonic transit time asso-
ciated or not with delayed rectosigmoid transit time;
- Right colonic stasis: delayed right colonic transit time 
associated or not with delayed left colonic and recto-
sigmoid transit times;
- Normal colonic transit: normal colonic transit in the 
three segments.
The upper limits of the normal range for right colon, 
left colon, and rectosigmoid total colonic transit time were, 
respectively, 62, 18, 20, and 34 hours.19
Oroanal transit time of carmine
Children were given 500 mg oral carmine diluted in 50 
mL water. Mothers were instructed to write down the date 
and time when the stools changed color. Oroanal transit time 
was defined as the time between the ingestion of carmine 
dye and its initial appearance with stools.23
Statistical analysis
Statistical calculations were conducted using the Jandel 
Sigma Stat software. In all cases, the level of rejection for 
null hypothesis was set at a p value less than or equal to 
0.05 (5.0%). The several tests used are specified along 
with the results. Median and 25th and 75th percentiles 
(shown in parentheses) were used to express those 
variables with non-normal distribution. The other variables 
were expressed as mean and standard deviation.
The project was analyzed and approved by the Research 
Ethics Committee of UNIFESP-EPM. Written and signed 
informed consent was obtained from children’s guardians 
and from those children aged over 12 years.
Results
A total of 34 patients with median age (25th and 75th 
percentiles) of 93.7 (74.3-107.4) months were included in 
the study, minimum age of 3 and maximum of 13 years. 
Regarding sex, 19 were boys and 15 were girls. Median 
age at onset of constipation was 12 (4 and 48) months. In 
15 (44.1%) of 34 patients, first symptoms occurred during 
the first year of life, in six (40.0%) of these 15 patients 
occurring during the first 6 months of life. Soiling was 
found in 29 (85.3%) of 34 patients. Median age at onset of 
soiling was 60 (48 and 68) months. Soiling starting before 
48 months of age occurred in nine (31.0%) of 29 patients. 
These nine patients had already learned sphincter control 
before the onset of soiling. Median soiling frequency was 
7 (3 and 7) days per week, i.e., most patients presented 
daily soiling. Of the 34 patients admitted, only one did not 
attend follow-up clinical and transit time reassessment at 
the eighth week of treatment, since the family moved to 
another city.
Table 1 shows clinical characteristics of 33 patients 
reassessed at the sixth week of treatment. At the sixth 
week of treatment, 30 (90.9%) of 33 patients were 
asymptomatic. Of the remaining three symptomatic 
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Characteristics Admission, n (%) Sixth week, n (%) p*
Effort during defecation 32 (97.0) 2 (6.0) 0.001
Pain during defecation 32 (97.0) 2 (6.0) 0.001
Abdominal pain 29 (87.9) 5 (15.1) 0.001
Soiling 28 (84.4) 1 (3.0) 0.001
Fear of defecation 15 (45.5) 1 (3.0) 0.001
Fecal retention 13 (39.4) 1 (3.0) 0.001
Less than three defecations per week 25 (75.7) 1 (3.0) 0.001
Defecation frequency per week 1.0 (1.0-2.0)†  6.0 (5.0-6.0)† 0.001‡
Table 1 - Clinical characteristics of 33 patients with chronic functional constipation at admission and 
at the sixth week of treatment
*	McNemar	test.
†
	Median	and	25th	and	75th	percentiles.
‡
	Wilcoxon	test.
Transit time Admission Sixth week p
Orocecal   
 Lactulose (minutes) 70 (50-70) 50 (48-60) 0.002
 Beans (minutes) 240 (220-260) 220 (200-240) 0.002
Oroanal   
 Carmine (hours) 62.0 (46.7-120.0) 30.0 (24.0-45.2) 0.001
Colonic   
 Right colon (hours) 13.0 (6.5-27.0) 11.0 (5.5-18.5) 0.001
 Left colon (hours) 27.5 (12.5-41.0) 9.5 (15.5-25.5) 0.001
 Rectosigmoid (hours) 28.5 (19.0-40.0) 9.5 (15.5-25.5) 0.001
 Total colonic (hours) 69.5 (52.5-104.5) 37.0 (27-51.5) 0.001
Table 2 - Total and segmental orocecal, oroanal, and colonic transit times of patients (n = 33) with 
chronic functional constipation at admission and at the sixth week of treatment
Values	expressed	as	median	and	25th	and	75th	percentiles	in	parentheses,	Wilcoxon	test.
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patients, one patient showed persistence of soiling, pain and 
effort during defecation; one patient showed pain during 
defecation; and another patient showed fear of defecation. 
Statistical analysis revealed statistically significant reduction 
in all clinical manifestations of constipation in relation to 
baseline assessment. A statistically significant increase 
was observed in the number of weekly defecations.
Table 2 shows orocecal transit times after lactulose 
administration and after a bean test meal at admission 
and at the sixth week of treatment. Statistical analysis 
revealed statistically significant reduction in both lactulose 
and bean orocecal transit times. A statistically significant 
reduction was also observed in oroanal transit time and 
total and segmental colonic transit times. It is worth 
mentioning that all patients analyzed both at admission 
and at the sixth week of treatment and after a 1-year 
treatment were hydrogen producers.
Taking into account the 64 measurements of oroanal 
carmine and total colonic transit times with radiopaque 
markers, Sperman’s correlation coefficient was calculated, 
being equal to +0.87 (p < 0.001).
Two of 34 patients included in the study were not 
reassessed for total and segmental colonic transit times 
at the sixth week (one moved to another city, and the 
other did not undergo these examinations but continued 
with treatment and follow-up). Regarding the pattern of 
colonic motility disorder at the sixth week of treatment, 22 
(68.7%) of 32 patients showed normal transit time in the 
three segments. In the remaining patients: three (9.4%) 
showed right colonic stasis, three (9.4%) showed distal 
obstruction, and four (12.5%) showed outlet obstruction, 
as described in Table 3.
When possible, patients with chronic functional 
constipation were reassessed 6 and 12 months after 
admission to the study.
At month 6, a clinical reassessment was performed in 
33 of the 34 initial study patients. Of these 33 patients, 
28 (84.8%) were asymptomatic. Five (15.2%), despite 
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Admission n (%) Sixth week n
Normal 9 (28.1) Normal 9
Right colonic stasis 11 (34.4) Normal 5
  Right colonic stasis 2
  Distal obstruction 3
  Outlet obstruction 1
Distal obstruction 10 (31.3) Normal 7
  Right colonic stasis 1
  Outlet obstruction 2
Outlet obstruction 2 (6.3) Normal in the three segments 1
  Outlet obstruction 1
Table 3 - Pattern of colonic motility disorder of patients with chronic functional constipation at admission and at the sixth week 
of treatment
Sixth	week:	normal,	n	=	22	(68.8%);	right	colonic	stasis,	n	=	3	(9.4%);	distal	obstruction,	n	=	5	(15.6%);	outlet	obstruction,	n	=	4	(12.5%).
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regular use of mineral oil, needed one or two rectal enemas 
for fecal disimpaction after maintenance treatment had 
started. At this assessment, only six (18.1%) patients 
did not need mineral oil to maintain a positive bowel 
habit.
At month 12, 24 (72.7%) of 33 patients remained 
on follow-up. Of these 24 patients, 22 (91.6%) were 
asymptomatic. Two (8.3%) needed intestinal lavage when 
mineral oil was discontinued. After reintroduction of the 
laxative, positive bowel habit was reinstated. Of the 24 
patients, 12 (50.0%) continued on mineral oil. Of these 
12 patients, 10 (83.3%) had shown total colonic transit 
time higher than 62 hours before treatment started, 
whereas six (50.0%) of the 12 who did not need mineral 
oil showed total colonic transit time higher than 62 hours 
(p = 0.193, two-tailed Fisher’s exact test). At the sixth week 
of treatment, the 12 (100%) who did not need mineral oil 
at month 12 showed total colonic transit time lower than 
62 hours, whereas, of the 12 who still needed mineral oil 
at month 12, only six showed normal total colonic transit 
time lower than 62 hours at the sixth week of treatment 
(p = 0.014, two-tailed Fisher’s exact test).
Of the 24 patients, 17 (70.8%) agreed to repeat, at 
month 12, orocecal transit time with bean test meal and 
oroanal transit time (carmine). Table 4 shows orocecal and 
oroanal transit times of these 17 patients at admission, at 
the sixth week of treatment and after a 12-month follow-
up period. It is important to point out that, prior to the 
assessments at 12 months, administration of laxative was 
discontinued in all patients for at least 15 days.
Discussion
At the sixth week of treatment, including mineral oil 
administration, we observed a statistically significant 
reduction in lactulose and bean test meal orocecal transit 
times, in oroanal transit time of carmine, and in total colonic 
transit time measured with radiopaque markers (Table 2). We 
also observed changes in the patterns of colonic dysmotility 
toward normal patterns or exclusive involvement of distal 
colonic portions (Table 3). At this time point, almost all 
patients showed positive clinical response, indicating that 
dysmotility patterns at admission are not predictive of 
outcome at the initial phase of treatment, even for those 
patients who showed right colon stasis. Decreased transit 
is likely to have resulted from cessation of fecal retention 
and fecaloma emptying, neutralizing the phrenocolonic 
reductive effect on the proximal motility of the digestive 
tube.8,11,12 Only one study analyzed orocecal transit time 
during treatment and did not show its reduction,24 in 
opposition to our data, which showed a decrease in this 
parameter using both lactulose and bean test meal. It is worth 
mentioning that dysmotility of the proximal digestive tube 
may be associated with symptoms in the upper abdomen, 
such as early saciety, which may disappear after fecaloma 
emptying.6,8,10,12
Regarding total and segmental colonic transit times, 
it is difficult to compare our results with the few studies 
found in the literature, considering that distinct therapy 
regimens14,16,24,25 or patients with constipation associated 
with neurological involvement were analyzed.15 Regarding 
our patients with clinical symptoms improved upon 
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Transit time Admission Six weeks 12 months p
Bean orocecal (minutes) 240.0 (215.0-240.0) 220.0 (200.0-245.0)* 200.0 (180.0-230.0)* 0.006
Carmine oroanal (hours) 62.0 (46.8-202.5) 30.0 (23.0-44.5) 30.0 (24.0-49.0) 0.001
Table 4 - Bean test meal orocecal transit time and oroanal transit time at admission and at 6-week and 1-year clinical follow-
ups in patients (n = 17) with chronic functional constipation
Median	and	25th	and	75th	percentiles	in	parentheses,	Friedman	test	with	Dunn	multiple-comparison	test.
*	p	<	0.05.
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prescription of therapy regimen, one can speculate that a 
reduction in colonic dimensions may have occurred, which 
could have contributed to returning to a normal peristaltic 
function. This hypothesis cannot be confirmed in practice 
due to ethical restrictions inherent to colon-contrasted serial 
radiographs to demonstrate reduction in its dimensions. 
Within this context, in the group of 17 patients who agreed 
to repeat the measurement of carmine oroanal transit time 
after one year of treatment, mineral oil discontinued for 
at least 2 weeks, median time remained at 30 hours as 
observed since the sixth week of treatment, pointing out 
a high correlation (r = +0.89) between total and oroanal 
colonic transit time of carmine. These results could be 
interpreted as suggesting, in children, that colonic motility 
abnormalities of functional constipation might be reversed, 
even after cessation of laxatives, that is, they are secondary 
to constipation.
Our data also show a higher probability of laxative 
need after 1 year of treatment in patients with persistence 
of delayed total colonic transit time at the sixth week of 
treatment, underscoring the importance of the initial phase 
of treatment. In Dutch children with functional constipation 
treated with a therapy regimen similar to that used in 
the present study, the authors observed that a negative 
evolution after 1 year of treatment was associated with a 
total colonic transit time higher than 100 hours.12 In our 
study, we observed that, at admission, nine (28.4%) of the 
34 patients showed total colonic transit time higher than 
100 hours (data not shown). After a 12-month follow-up 
period, six of these nine patients remained on mineral oil, 
confirming that a total colonic transit time higher than 
100 hours at baseline assessment may be an indicator 
of a worse prognosis. We should highlight that, due to 
the small number of patients, no statistically significant 
association was obtained. Thus, in our opinion, the main 
limiting factor of our study lies in the lack of possibility 
to repeat baseline assessments after a 1-year follow-up, 
which is common in clinical studies in which some patients 
are expected to withdraw treatment protocol, especially 
those fully recovered. Another aspect refers to patient 
severity, that is, the results from the present study cannot 
be extrapolated to all functionally constipated children, 
especially to those with less severe functional constipation 
who do not attend specialized clinics.12,26-28
Of the patients followed for up to 1 year after treatment, 
half of them still needed mineral oil to maintain an 
adequate bowel habit, which is consistent with the scarce 
information found in the literature concerning improvement 
of clinical symptoms of constipated patients followed for 
at least 1 year in specialized clinics.
In conclusion, the conventional therapeutic approach 
yielded good results regardless of the presence or not of 
colonic dysmotility at inclusion in the study. The persistence 
of delayed total colonic transit time at the sixth week 
of treatment indicates a higher probability of laxative 
need after 1 year of treatment. Digestive tract motility 
abnormalities in functionally constipated children may be 
reversed, and may be secondary to constipation.
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